Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. The Business Development and Strategy Intern will support the Business Development and External Innovation team by contributing to strategic initiatives, operational projects, and day-to-day business activities. This role is designed to provide meaningful, hands-on experience in a professional pharmaceutical environment, offering exposure to cross-functional collaboration, business processes, and industry best practices. The candidate will contribute to the execution of a detailed analysis of indications for Acadia to target for inlicensing and partnering opportunities. This internship is a great opportunity for someone interested in Pharmaceutical R&D strategy development and decision making. Learn more about our internship program here.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern